Best Life Sciences Companies in Northern District, Israel
The 105 best Life Sciences companies in Northern District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Lumenis.
Our analysis of 50 Life Sciences companies
$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Northern District
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Lumenis Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets | $214M | 203 mo ago | Acquired | 102 | 1973 | 778 patents Medical laser and fiber-optic devices for aesthetic, therapeutic, and diagnostic procedures | 1 partnership |
| 2 | Augmedics Provider of an augmented reality guidance system for surgery 69AI top 15%Product top 21%Funding top 27%Moat top 28% All 12 signals ▾AItop 15% Producttop 21% Fundingtop 27% Moattop 28% Innovationtop 34% Patentstop 36% Growthtop 45% Techtop 45% Markettop 48% Talentbottom 49% Globalbottom 37% Newsbottom 21% AI: Holds AI/ML patents (G06N-family CPC) Product: 5 distinct product lines · Company stage: Series D rank vs industry peers · Fliar Intelligence Index 69/100 | $143M | 35 mo ago | Series D | 109 | 2014 | 190 patents Image-guided spinal surgery visualization and instrument navigation systems | — |
| 3 | Rapid Medical Developer of neurovascular interventional devices such as distal access & microcatheters | $79M | 61 mo ago | Series D | 120 | 2008 | 219 patents Minimally invasive vascular access devices and guidewire actuation/control technologies. | — |
| 4 | ForSight Robotics Provider of an AI-based ophthalmic surgical robot for healthcare professionals 76Innovation top 26%Patents top 27%Growth top 28%Moat top 28% All 10 signals ▾Innovationtop 26% Patentstop 27% Growthtop 28% Moattop 28% Fundingtop 29% Techtop 45% AItop 45% Marketbottom 47% Globalbottom 40% Newsbottom 18% Innovation: 70 patents (top 39% of patent-holders) · 70 filings since 2022 vs 0 in 2017-21 Patents: 70 patents matched (strict assignee match) · 70 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 76/100 | $65M | 11 mo ago | Series B | 50 | 2020 | 70 patents Robotic microsurgery hardware: control, input, magnetic sensing, kinematics, and sterile drapes. | 2 awards |
| 5 | Biond Biologics Developer of immunotherapies for oncology and autoimmune diseases | $32M | 55 mo ago | Series C | 34 | 2016 | 141 patents Immuno‑oncology biologics: intracellular delivery systems and checkpoint‑blocking antibodies (ILT2/3, CD28). | — |
| 6 | Realview Imaging Provides 3D holographic display based solutions for medical imaging applications | $25M | 58 mo ago | Series C | 14 | 2008 | — | 1 job opening |
| 7 | Vibrant Developer of chemical-free vibrating capsules for the treatment of constipation | $25M | 62 mo ago | Series E | 18 | 2007 | 144 patents Ingestible vibrating capsules for targeted gastrointestinal drug delivery and therapy. | — |
| 8 | Vessi Medical Provider of method for treating bladder cancer | $18M | 28 mo ago | Series A | 3 | 2015 | — | — |
| 9 | Mitrassist Supplementary valve for mitral regurgitation treatment | $17M | 103 mo ago | Series B | 15 | 2009 | — | — |
| 10 | Paragate Medical Implantable device for congestive heart failure patients | $13M | 41 mo ago | Seed | 10 | 2016 | — | — |
| 11 | Escala Medical Developing repair device for the treatment of pelvic organ prolapse (POP) 9Funding top 37%Global bottom 36%Market bottom 20% All 3 signals ▾Fundingtop 37% Globalbottom 36% Marketbottom 20% Funding: Raised $13.1M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Global: Investors from 2 countries beyond Israel rank vs industry peers · Fliar Intelligence Index 9/100 | $13M | 11 mo ago | Series A | 5 | 2014 | — | — |
| 12 | Nurami Medical Developer of nanofiber and sealant technology for the soft tissue repair 40Moat top 25%Growth top 35%Product top 35%Patents top 37% All 9 signals ▾Moattop 25% Growthtop 35% Producttop 35% Patentstop 37% Fundingtop 41% Innovationtop 42% Globalbottom 40% Techbottom 38% Marketbottom 28% Moat: Editorial + unicorn rating 7/10 · IP moat: 37 patents Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $12M | 15 mo ago | Series C | 16 | 2014 | 37 patents Patents concentrated in health & consumer products | 1 launch |
| 13 | Virility Medical Provider of a skin patch for the treatment of premature ejaculation | $10M | 47 mo ago | Series A | 9 | 2016 | 46 patents Electrical stimulation and mechanical devices for male sexual function and ejaculation control | 1 launch |
| 14 | Butterfly Medical Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH) 35Moat top 35%Patents top 36%Funding top 37%Talent top 38% All 8 signals ▾Moattop 35% Patentstop 36% Fundingtop 37% Talenttop 38% Innovationtop 39% Globalbottom 43% Techbottom 37% Marketbottom 26% Moat: Editorial + unicorn rating 5/10 · IP moat: 68 patents Patents: 68 patents matched (strict assignee match) · 34 filings since 2022 vs 31 in 2017-21 rank vs industry peers · Fliar Intelligence Index 35/100 | $9M | 1 mo ago | Acquired | 9 | 2014 | 68 patents Urological implants for periurethral tissue support and urinary incontinence treatment | — |
| 15 | OrthoSpin External fixation system for bone injuries, bone lengthening & limb deformities | $8M | 74 mo ago | Acquired | 8 | 2014 | 17 patents Motorized, adjustable spinal fixation strut devices for orthopedic surgery | — |
| 16 | Neuronix Develops new methods for treatment of alzheimer's disease for long term improvement of quality of life | $8M | 124 mo ago | Deadpooled | 16 | 2008 | 21 patents Non‑invasive brain stimulation systems for CNS disorder treatment and cognitive enhancement | — |
| 17 | Gordian Surgical A trocar with an integrated closure system | $7M | 79 mo ago | Series A | 7 | 2012 | 20 patents Laparoscopic trocar incision closure devices for minimally invasive surgery | — |
| 18 | ApiFix Implant for treatment of scoliosis | $5M | 85 mo ago | Acquired | 8 | 2011 | 105 patents Adjustable spinal fixation and biasing devices for vertebral implants | — |
| 19 | ProArc Medical Developer of minimally invasive BPH treatment solutions | $5M | 58 mo ago | Funding Raised | 7 | 2010 | 39 patents Urethral therapeutic devices and procedures for minimally invasive urinary tract treatment | — |
| 20 | BioCep Immunomagnetic cell isolation platform | $5M | 148 mo ago | Deadpooled | 5 | 2006 | 20 patents Magnetic isolation of rare cells for biomedical research and diagnostics | — |
| 21 | Anchora Medical Micro laparoscopic device for single & continuous suturing | $4M | 75 mo ago | Series B | 6 | 2014 | 36 patents Minimally invasive endoscopic suturing tools for internal tissue closure in surgery | — |
| 22 | ElastiMed Wearable compression stocking to prevent Deep vein thrombosis | $4M | 70 mo ago | Seed | 5 | 2015 | 43 patents Patents concentrated in electrical & electronics | — |
| 23 | Fidmi Medical Provider of an enteral feeding device for the treatment of gastrointestinal disorders | $4M | 56 mo ago | Seed | 3 | 2014 | — | — |
| 24 | Virtual Ports Micro-anchoring technology for laparoscopic surgery | $4M | 169 mo ago | Series A | 8 | 2006 | 27 patents Provides specialized minimally invasive surgical instruments and accessories for tissue manipulation. | — |
| 25 | Ark Surgical Manufacturer of organ retrieval devices in laparoscopic surgery | $3M | 26 mo ago | Seed | 10 | 2017 | 24 patents Minimally invasive surgery: laparoscopic tissue containment and workspace devices. | — |
| 26 | Nephera Develops product to improve treatment of acute heart failures | $3M | 190 mo ago | Deadpooled | — | 2008 | 11 patents Medical devices and methods for stimulating urinary system function | — |
| 27 | UPnRIDE Robotics Developing wheeled robotic device for upright and seated mobility | $3M | 110 mo ago | Seed | 5 | 2014 | 22 patents Adaptive wheelchair self‑leveling systems and ergonomic knee support for mobility devices | — |
| 28 | Trisol Medical Percutaneous solution for tricuspid valve disease | $3M | 52 mo ago | Seed | 19 | 2016 | 23 patents Transcatheter heart valve implantation devices and delivery mechanisms | — |
| 29 | Helix Medical Systems Ultrasound systems for breast imaging | $3M | 221 mo ago | Deadpooled | — | 2004 | — | — |
| 30 | HealiumMedical Developer of ablation systems for the treatment of atrial fibrillation | $3M | 45 mo ago | Funding Raised | 20 | 2017 | — | — |
| 31 | EndoCross Developing catheter system for the treatment of chronic total occlusions & other lesions | $2M | 221 mo ago | Deadpooled | 5 | 2006 | 34 patents Balloon catheter devices for minimally invasive vascular occlusion treatment | — |
| 32 | ZygoFix Provider of miniature screwless spine fusion implant | $2M | 50 mo ago | Seed | 4 | 2016 | 18 patents Spinal facet joint distraction/fusion prostheses and implant delivery systems | 2 launchs |
| 33 | SetBone Medical Developer of bone cement for the treatment of vertebral compression fractures | $2M | 52 mo ago | Seed | 4 | 2017 | — | — |
| 34 | Serenno Medical Developer of bedside urine output measuring device | $2M | 65 mo ago | Seed | 7 | 2016 | — | — |
| 35 | Ceretrieve Developer of medical devices for treating ischemic stroke | $2M | 65 mo ago | Seed | 7 | 2016 | 16 patents Embolus removal catheters and retrieval devices for vascular interventions | — |
| 36 | Regenovation Biotech drug development company working on drugs for tissue repair and regeneration | $1M | 130 mo ago | Deadpooled | — | 2015 | — | — |
| 37 | Aqueduct Medical Developing cervical dilator device for intrauterine procedures | $1M | — | Seed | 4 | 2013 | — | — |
| 38 | Guide in Medical Developing guided intubation systems for trachea visualization | $1M | 112 mo ago | Seed | 2 | 2015 | — | — |
| 39 | Infiniplex Developer of liquid-biopsy based screening test for cancer | $1M | 48 mo ago | Seed | 8 | 2020 | 9 patents Multiplex nucleic acid diagnostic kits and selective PCR primers for rare target detection | — |
| 40 | Juvenis Developer of biopolymers for tissue augmentation & reconstruction | $1M | 171 mo ago | Seed | — | 2007 | 9 patents Biodegradable polymer gel systems for soft tissue repair and augmentation | — |
| 41 | Stimatix GI Medical devices to aid patients with intestinal blockage or Crohn’s Disease | $1M | 183 mo ago | Seed | 8 | 2009 | 48 patents Ostomy appliance components: compact devices, sealing systems, and gas filtration/release mechanisms. | — |
| 42 | IDD Therapeutics Developing small molecule drugs for cancer | $1M | — | Deadpooled | — | 2010 | — | — |
| 43 | Engineering for All Provider of point of care diagnostic device | $900K | 26 mo ago | Series A | 12 | 2016 | — | — |
| 44 | Implant-B Multi-piece dental implant for the treatment of peri-implantitis | $795K | 117 mo ago | Deadpooled | 2 | 2014 | 14 patents Reusable dental implant components and one‑time abutment systems for removable prosthetic sleeves | — |
| 45 | Deliverance Developing catheters for the bleed management during surgeries | $700K | 166 mo ago | Deadpooled | — | 2009 | 7 patents Vascular closure devices for sealing arterial puncture sites | — |
| 46 | Arcuro Medical Developer of a repair system for meniscus tears of the knee | $670K | 17 mo ago | Series A | 12 | 2013 | — | — |
| 47 | CartiCure Early stage MedTech company focusing on cartilage repair products | $600K | — | Deadpooled | — | 2005 | 5 patents Non‑autologous cartilage regeneration using flexible chondrocyte film scaffolds | — |
| 48 | ST Stent Flexible nasal stent | $450K | 90 mo ago | Seed | 3 | 2013 | — | — |
| 49 | EndoGI Developer of a stent delivery system | $112K | 77 mo ago | Funding Raised | 5 | 2017 | — | — |
| 50 | NextFerm Provider of non-GMO technology for improved yeast strains | $111K | 77 mo ago | Funding Raised | 30 | 2013 | — | — |
Top 12 Life Sciences companies in Northern District
#1
Acquired · Yokneam Illit, Northern District · founded 2014 · 9 employees$9Mraised▾
Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH). The company's flagship product is a non-surgical device that is different from a conventional surgical treatment that requires a certain level of recovery and involves complications. It claims that the device can be delivered at the comfort of the physician’s office and provides immediate relief.
- May 2026Series C$21M
- Sep 2023Grant (prize money)$2.7M
- Oct 2020Series B$7M
- Jan 2020Angel$2M
#2
Series B · Yokneam Illit, Northern District · founded 2020 · 50 employees$65Mraised▾
Provider of an AI-based ophthalmic surgical robot for healthcare professionals. The company has developed a next-generation robotic platform that has features for image visualization, robotic microsurgical technology, and cognitive computing methods. The microsurgical instrument has been built to be used for delicate surgery procedures using AI-based technology.
- Jun 2025Series B$125M
- Apr 2022Series A$55M
- Mar 2021Series A$10M
#3
Series A · Misgav, Northern District · founded 2014 · 5 employees$13.1Mraised▾
Escala Medical is focussed on developing a device for the treatment of pelvic organ prolapse (POP). It has developed a device whose approach mirrors the surgery-based repair to fix the vaginal apex to the sacrospinous ligament (SSL). As of September 2016, the device is in technological development and claims to be a nonsurgical, incision-free, mesh-free repair approach.
- Jun 2025Series A$4.5M
- Oct 2023Grant (prize money)$2.6M
- Jun 2023Grant (prize money)—
- Jun 2023Seed—
#4
Series C · Nazareth, Northern District · founded 2014 · 16 employees$12.4Mraised▾
Nurami Medical is a developer of nanofiber and sealant technology for soft tissue repair. It has developed its first product which is a dural substitute patch for neurosurgeries to prevent cerebrospinal fluid leakage and regenerate the damaged dura protecting the brain. The product is in preclinical trials. It is also working on the next-generation of ArtiFascia that will be able to adhere to tissues without the need for sutures.
- Mar 2025Series C$30M
- Nov 2020Series B$6M
- Dec 2016Seed$645.8K
- 2014Seed$800K
#5
Series D · Yokneam Illit, Northern District · founded 2014 · 109 employees$142.6Mraised▾
Augmedics provides an augmented reality-guided surgery system. It includes see-through glasses to guide and support the surgeon. The system's first development is the Spine Surgery application which aims to improve the insertion of screws into the vertebrae.
- Jun 2023Series D$82.5M
- Mar 2021Series C$36M
- Jun 2020Series B$15M
- Sep 2017Series A$8.3M
#6
Series A · Misgav, Northern District · founded 2015 · 3 employees$18.2Mraised▾
Vessi Medical develops a method for treating Non-Muscle Invasive Bladder Cancer (NMIBC). The company uses surface cryotherapy, a method that utilizes extreme cold, to freeze and destroy abnormal tissue. The invasive solution for NMIBC provides a new, first-line, therapeutic alternative to surgery
- Feb 2024Series A$16.5M
- Aug 2020Seed$1.7M
#7
Series D · Yokneam Illit, Northern District · founded 2008 · 120 employees$79Mraised▾
Developer of neurovascular interventional devices such as distal access & microcatheters. Its first products include Comaneci, the first-ever controllable aneurysm neck-bridging device, and Pele, a large lumen distal access catheter. It has also developed TigerTriever that is a revascularization device that helps to monitor the dimensions of blocked blood vessels that cause an acute ischemic stroke.
- May 2021Series D$50M
- Apr 2019Series C$20M
- Jul 2017Series B$9M
#8
Acquired · Yokneam Illit, Northern District · founded 1973 · 102 employees$214Mraised▾
Lumenis develops minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets. In surgical segment their offering includes products for urology, ENT, gynecology and gastroenterology. In aesthetic segment their offering includes hair removal and skin treatments products. In opthalmology segment their offering includes products for glaucoma, retinal diseases. They have presence in over 100 countries. Lumenis was acquired by Viola Group and Ofer Hi-Tech in 2006. XIO acquired Lumenis for $510M in 2015.
#9
Series A · Misgav, Northern District · founded 2013 · 12 employees$670Kraised▾
Developer of a repair system for meniscus tears of the knee. It uses proprietary SuperBall repair system that has developed a knotless all-suture implant and a delivery system for meniscus repair. The system preserves meniscus functionality, repairs hard-to-reach areas, provides full meniscus coverage and is easy to operate.
#10
Seed · Nazareth, Northern District · founded 2016 · 10 employees$13.4Mraised▾
Paragate Medical is developing an implantable device for the heart failure patients. Based on the specific anatomical membrane’s properties and through a patented absorption element, it is developing its flagship product which is a minimally invasive device that is capable of removing the excess extracellular fluid from the body & offers a therapeutic benefit by reducing blood volume & pressure overload. As of November 2016, the company is operating within NGT3 incubator & has finished preclinical feasibility testing.
- Jan 2023Grant (prize money)$11M
- Jul 2021Grant (prize money)$59.4K
- Aug 2019Grant (prize money)$2.3M
- Nov 2018Grant (prize money)$56.9K
#11
Series C · Misgav, Northern District · founded 2016 · 34 employees$32Mraised▾
Developer of immunotherapies for oncology and autoimmune diseases. The lead candidate BND 22 is an immune checkpoint inhibitor for solid tumors, BION-206 is a VHH antibody, enhances phagocytosis, and BND-35 is an antibody targeting ILT3 receptor for the treatment of solid tumors. The INspire technology is a platform for the internalization of antibodies into cells, addressing “undruggable” intracellular targets.
- Nov 2021Series C$15M
- Jan 2019Series B$17M
#12
Seed · Nazareth, Northern District · founded 2017 · 10 employees$3.2Mraised▾
Manufacturer of organ retrieval devices in laparoscopic surgery. The company offers LapBox, is a groundbreaking tissue containment system that reduce the risk of cancerous tissue dispersion during laparoscopic surgery and enable contained minimally invasive procedures instead of high-risk open surgery.
- Mar 2024Seed$1.1M
- Jun 2021Seed$2.1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.